VPRIV (velaglucerase alfa) — NDC 54092-701 by Takeda Pharmaceuticals America, Inc.
VPRIV (velaglucerase alfa) — NDC 54092-701 by Takeda Pharmaceuticals America, Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: VPRIV; Generic name: velaglucerase alfa; Product NDC: 54092-701.
| Brand name | VPRIV |
|---|---|
| Generic name | velaglucerase alfa |
| Product NDC | 54092-701 |
| Labeler | Takeda Pharmaceuticals America, Inc. |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active ingredients | VELAGLUCERASE ALFA 2.5 mg/mL |
| Pharmacologic class | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
| Marketing category | BLA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →